Your browser doesn't support javascript.
loading
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors.
Mahadevan, D; Plummer, R; Squires, M S; Rensvold, D; Kurtin, S; Pretzinger, C; Dragovich, T; Adams, J; Lock, V; Smith, D M; Von Hoff, D; Calvert, H.
Afiliación
  • Mahadevan D; Arizona Cancer Center, Tucson, USA. Electronic address: dmahadevan@azcc.arizona.edu.
  • Plummer R; Northern Centre for Cancer Care, Newcastle upon Tyne.
  • Squires MS; Astex Therapeutics Limited, Cambridge, UK.
  • Rensvold D; Arizona Cancer Center, Tucson, USA.
  • Kurtin S; Arizona Cancer Center, Tucson, USA.
  • Pretzinger C; Arizona Cancer Center, Tucson, USA.
  • Dragovich T; Arizona Cancer Center, Tucson, USA.
  • Adams J; Northern Centre for Cancer Care, Newcastle upon Tyne.
  • Lock V; Astex Therapeutics Limited, Cambridge, UK.
  • Smith DM; Astex Therapeutics Limited, Cambridge, UK.
  • Von Hoff D; Arizona Cancer Center, Tucson, USA.
  • Calvert H; Northern Centre for Cancer Care, Newcastle upon Tyne.
Ann Oncol ; 22(9): 2137-2143, 2011 Sep.
Article en En | MEDLINE | ID: mdl-21325451

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2011 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2011 Tipo del documento: Article Pais de publicación: Reino Unido